Publication & Citation Trends
Most Cited Works
Publications
24 total
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study PDF
Cited by 50
OpenAlex
Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study
Cited by 111
OpenAlex
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
Cited by 54
OpenAlex
Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission
Cited by 5
OpenAlex
Revalidation of FLIPI in patients with follicular lymphoma (FL) registered in the F2 study and treated upfront with immunochemotherapy
Cited by 6
OpenAlex
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
Cited by 1,497
OpenAlex
Multi-centre, phase II study of combination antibody therapy with epratuzumab plus rituximab in relapsed/refractory indolent and aggressive NHL: Promising preliminary results
Cited by 5
OpenAlex
An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma.
Cited by 42
OpenAlex
Research Topics
Lymphoma Diagnosis and Treatment
(13)
Chronic Lymphocytic Leukemia Research
(8)
Viral-associated cancers and disorders
(6)
Multiple and Secondary Primary Cancers
(3)
Acute Myeloid Leukemia Research
(2)
Frequent Co-Authors
Affiliations
Goethe University Frankfurt
St Bartholomew's Hospital
Hôpital Beaujon
Centre Hospitalier Universitaire de Lille
Centre Hospitalier Universitaire Henri-Mondor